GILEAD 701 (Truvada 200 mg / 300 mg)
Generic Name: emtricitabine/tenofovir
Pill imprint GILEAD 701 has been identified as Truvada 200 mg / 300 mg.
Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 200 mg / 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GILEAD 701 (Truvada 200 mg / 300 mg)
- Generic Name:
- 200 mg / 300 mg
- 19.00 mm
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Gilead Sciences
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|54569-5588||A S Medication Solutions LLC (repackager)|
|54868-5141||Physicians Total Care Inc (repackager)|
|55045-3481||Dispensing Solutions Inc. (repackager)|
|35356-0070||Lake Erie Medical and Surgical Supply (repackager)|
|52959-0969||H.J. Harkins Company, Inc (repackager)|
Note: Inactive ingredients may vary.
More about Truvada (emtricitabine / tenofovir)
- Other brands: AccessPak for HIV PEP Basic
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...